Clinical Trials Browser

Phase 1/2 × gallium Ga 68 dotatate × 90 days × Clear all

NCT06427798 2026-03-10

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Phase 1/2 Recruiting

Paraganglioma, Pheochromocytoma

NCT07150806 2025-12-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Phase 1/2 Recruiting

Meningioma